|Title||Associate Clinical Professor|
|School||University of California, San Diego|
|Address||9500 Gilman Drive #0987|
CA La Jolla 92093
Dr. Helsten focuses first and foremost on providing excellent care for breast cancer patients. She provides neoadjuvant, adjuvant, and metastatic treatments, including endocrine therapy, chemotherapy, and targeted therapies. She actively enrolls patients to clinical trials.
Dr. Helsten’s research is primarily focused on clinical trials chosen to bring the most cutting edge care to her patients. She runs several clinical trials and enrolls patients to these and cooperative group and investigator initiated trials at UCSD. She is a coinvestigator of the groundbreaking I-SPY 2 study (www.ispy2.org). She is actively engaged in the design and implementation of translational research projects in breast cancer. FGFR inhibitors are of particular interest.
Education and Training
BS - Chemistry, Massachusetts Institute of Technology - 1990
MD - University of California, Davis - 1998
Resident - Harbor-UCLA Medical Center - 1998-2001
Chief Resident - Harbor-UCLA Medical Center - 2001-2002
Oncology Fellowship - UC San Diego Medical Center - 2002-2005
Medical oncology, Breast cancer, Clinical Trials, FGFR, Fibroblast growth factor, Fibroblast growth factor receptor
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share similar concepts with this person.